The website of Pathology In Practice Magazine

A statement on the new Omicron variant of SARS-CoV-2 (B.1.1.529)

Geoff Twist, Managing Director, Roche Diagnostics UK and Ireland has issued a statement on the new Omicron variant.

He said: “Our experts have analysed the publicly available sequences of the Omicron variant and we are assured that our tests to confirm COVID-19 infection continue to be accurate and reliable.
 
“While the news of the new Omicron variant is worrying for many, it’s important to remember that, like SARS-CoV-2, many viruses mutate over time. Accurate testing is already helping to build an understanding of the spread of this variant and in the coming days and weeks will provide important information to help us steer the course of action most likely to mitigate its impact.”

For further information you can read the full statement here.

Upcoming Events

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2022 Step Communications Ltd. Registered in England. Registration Number 3893025